Clinical Trial Update: Vitamin D Supplementation for Extremely Preterm Infants [Phase 2, Phase 3]

View source ↗

Summary

A Phase 2/Phase 3 clinical trial evaluating vitamin D supplementation in extremely preterm infants has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bronchopulmonary Dysplasia
• Vitamin Deficiency

Drugs mentioned

• Vitamin D3 (Cholecalciferol) (Cholecalciferol)

Snippet

Sponsor: University of Alabama at Birmingham | Conditions: Vitamin D Deficiency, Preterm Infants | Phase 2, Phase 3 | Status: COMPLETED